7
Feb
2019

Meet the Kilimanjaro Climb to Fight Cancer Team

Please subscribe and tell your friends why it’s worthwhile. Quality journalism costs money. When you subscribe to Timmerman Report at $169 per year, you reward quality independent biotech reporting, and encourage more.

 
 

You may also like

Three Lessons for Business Ahead of JPM, from the Kilimanjaro Climb to Fight Cancer
Join Me and a Biotech Team on the Trek of a Lifetime for Cancer Research
An Unforgettable Experience: The Kilimanjaro Climb to Fight Cancer Yearbook
Thank You, Biotech: Kili Climb to Fight Has Crushed Its $1m Goal for Cancer Research